Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer.
about
Lung cancer cells that survive ionizing radiation show increased integrin α2β1- and EGFR-dependent invasivenessMMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy.Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors.Molecular biology of head and neck cancer: risks and pathways.Synthetic genistein glycosides inhibiting EGFR phosphorylation enhance the effect of radiation in HCT 116 colon cancer cells.Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases.Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck.Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab.Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma.Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours.Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness.
P2860
Q27310015-D30214B6-8D51-4CDF-A41A-94F062FF4B5FQ33570512-B3442C9F-F22F-4281-9071-EF49A1E5E981Q33591405-A6B7C745-D958-42ED-B3E2-B1A448CD0434Q33972586-FC14EA34-F686-4DF1-A2E5-FD3F551DD1A4Q35220347-418A848C-37E6-4CC2-B0BD-908134809A83Q36412543-A1FA7730-3945-41CA-98B0-EA3383BC379FQ37325829-27167BBD-82A7-4EB4-893C-C90A9A009ACAQ38940074-C581BEB3-FAF5-4DBE-AAED-046A41B66B8DQ39600014-3D8E8233-0FFB-40CD-BE95-CF4AEA3F03C5Q43447566-6E1C7B4D-2D5E-4216-984B-A03C4AC97A6CQ43757821-2E12A49A-0536-490E-B376-1F368519DBB5Q44532853-0B8F06F7-95AE-4B3E-B521-BABA6E19837FQ44877290-658DA543-C044-4097-B190-DFAD73C7A286Q50034271-A1648BF4-FDB4-44F2-A250-6E87DD6BB31B
P2860
Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Integrating radiotherapy with ...... tment of head and neck cancer.
@ast
Integrating radiotherapy with ...... tment of head and neck cancer.
@en
type
label
Integrating radiotherapy with ...... tment of head and neck cancer.
@ast
Integrating radiotherapy with ...... tment of head and neck cancer.
@en
prefLabel
Integrating radiotherapy with ...... tment of head and neck cancer.
@ast
Integrating radiotherapy with ...... tment of head and neck cancer.
@en
P2860
P1476
Integrating radiotherapy with ...... tment of head and neck cancer.
@en
P2093
K Kian Ang
Luka Milas
P2860
P304
P356
10.1016/J.IJROBP.2007.06.076
P407
P577
2007-11-01T00:00:00Z